- Navigation
- Register My DNA Kit
- Features
- Pricing
- FAQ
- About
- Labs
- Login
- Get started
Interaction | References |
---|---|
[alvocidib co-treated with gemcitabine] results in decreased expression of BCL2 protein | R |
Interaction | References |
---|---|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein] | R |
Interaction | References |
---|---|
[alvocidib co-treated with gemcitabine] results in increased cleavage of CASP3 protein | R |
Interaction | References |
---|---|
4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of gemcitabine] | R |
Interaction | References |
---|---|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to gemcitabine]] | R |
Interaction | References |
---|---|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [EGF promotes the reaction [TGFB1 results in decreased susceptibility to gemcitabine]] | R |
Interaction | References |
---|---|
[DNMT1 protein binds to SFN promoter] inhibits the reaction [gemcitabine results in decreased susceptibility to gemcitabine] | R |
Interaction | References |
---|---|
[Calcitriol co-treated with gemcitabine] results in increased expression of CASP9 protein | R |
Interaction | References |
---|---|
[alvocidib co-treated with gemcitabine] results in increased expression of CDKN1A protein | R |
Interaction | References |
---|---|
BAY 11-7085 inhibits the reaction [gemcitabine results in increased expression of CNR2 mRNA] | R |